Delivery Order SPE2DB22D9101-SPE2DB25FU7LS

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for MENVEO A-C-Y-W KIT (2 VIALS), valued at $3,898.80 with a completion date of August 10, 2023. The order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $3,566.40 and a performance period through December 30, 2024. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product used for immunization purposes. This delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $7,206.20, for the supply of MENVEO A-C-Y-W KIT (2 VIALS)S. The contract has an ultimate completion date of April 22, 2025 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc....
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a Delivery Order under the SPE2DB program, valued at $3,603.10, for the supply of MENVEO A-C-Y-W KIT (2 VIALS). The contract has a period of performance through April 17, 2025 and is a Firm Fixed Price delivery order. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999...
This federal contract award, valued at $3,603.10, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, with a completion date of April 17, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,676.34, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,467.32 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $3,603.10 and a period of performance through April 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
This federal contract award, with ID SPE2DB20D6037|SPE2DB24FTXC4, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,538.59 firm fixed-price delivery order is for MENVEO A-C-Y-W KIT (2 VIALS)S, which the company will supply to support the recurring medical supply needs of military health facilities worldwide. The award is part of a larger indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W vaccines, with a ceiling value of $1,080.93 and a performance period through May 1, 2025. The contract is not set aside and was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999...
  • SPE2DB22D9101
    Indefinite Delivery Contract
  • SPE2DB22D9101-SPE2DB25FU7LS
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product, with a ceiling value of $1,441.24 and an ultimate completion date of May 20, 2025. The contract was awarded on May 19, 2025 and does not have a set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 8/18/25, 9:48 AM